Drug repurposing has become an important branch of drug discovery. Several computational approaches that help to uncover new repurposing opportunities and aid the discovery process have been put forward, or adapted from previous applications. A number of successful examples are now available. Overall, future developments will greatly benefit from integration of different methods, approaches and disciplines. Steps forward in this direction are expected to help to clarify, and therefore to rationally predict, new drug-target, target-disease, and ultimately drug-disease associations.
On the integration of in silico drug design methods for drug repurposing / MARCH VILA, Eric; Pinzi, Luca; Sturm, Noã; Tinivella, Annachiara; Engkvist, Ola; Chen, Hongming; Rastelli, Giulio. - In: FRONTIERS IN PHARMACOLOGY. - ISSN 1663-9812. - 8:MAY(2017), pp. 1-7. [10.3389/fphar.2017.00298]
On the integration of in silico drug design methods for drug repurposing
MARCH VILA, ERIC;PINZI, LUCA;TINIVELLA, ANNACHIARA;RASTELLI, Giulio
2017
Abstract
Drug repurposing has become an important branch of drug discovery. Several computational approaches that help to uncover new repurposing opportunities and aid the discovery process have been put forward, or adapted from previous applications. A number of successful examples are now available. Overall, future developments will greatly benefit from integration of different methods, approaches and disciplines. Steps forward in this direction are expected to help to clarify, and therefore to rationally predict, new drug-target, target-disease, and ultimately drug-disease associations.File | Dimensione | Formato | |
---|---|---|---|
On the integration drug repurposing Front Pharmacol 2017.pdf
Open access
Tipologia:
VOR - Versione pubblicata dall'editore
Dimensione
679.5 kB
Formato
Adobe PDF
|
679.5 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris